Press Releases
Herpes Cold Sore Product Xerclear® Launching for OTC Use in Europe | PRLog
Herpes Cold Sore Product Xerclear® Launching for OTC Use in Europe. The CBCD just learned that Medivir AB has announced that its cold sore product Xerclear®, is being launched for over-the-counter use by its partner GlaxoSmithKline in Europe. - PR11796726
In the Real Life Setting, Boosted REYATAZ® (atazanavir/ritonavir) Proves as Effective in Women
Boosted REYATAZ shows durable viral suppression in antiretroviral-experienced women living with HIV, in a gender-specific sub-analysis of a large retrospective cohort study.1
Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data from Phase 2 Study of
Abbott and Enanta Present Positive 12-Week Results and 3-Day Resistance Data from Phase 2 Study of ABT-450/r for Treatment of Hepatitis C
Medical News: More Oseltamivir Is on the Way - in Infectious Disease, Flu & URI from MedPage Today
A new supply of oseltamivir (Tamiflu) for oral suspension is being shipped to wholesalers and pharmacies, which should ease the current shortage, according to the FDA.
Pharma Quality Control | FDA Warns of Unapproved and Illegal H1N1 Drug Products Purchased Over the
The FDA is warning consumers to use extreme care when purchasing any products over the Internet that claim to diagnose, prevent, treat or cure the H1N1 influenza virus. The warning comes after the FDA recently purchased and analyzed several products represented online as Tamiflu (oseltamivir),
Viruses Resistant to Tamiflu Identified
The World Health Organization (WHO) has been informed by health authorities in Denmark, Japan and the Special Administrative Region of Hong Kong, China of the appearance of H1N1 viruses which are resistant to the antiviral drug oseltamivir (known as Tamiflu) based on laboratory testing.
BREAST-FEEDING NOW SAFER FOR INFANTS OF HIV-INFECTED MOTHERS
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding.
Martek Biosciences Corporation Newsroom - News Releases
Martek Biosciences Corporation (Nasdaq: MATK) is a leader in the innovation and development of DHA Omega-3 products that promote health and wellness through every stage of life. The Company produces life'sDHA™, a vegetarian source of the omega-3 fat
Respiratory Syncytial Virus (RSV) Prophylactic | PRLog
Respiratory Syncytial Virus (RSV) Prophylactic. The Respiratory Syncytial Virus Prophylactic Market is Expected to Show Static Growth during the Forecast Period - PR11771243
Clues to HIV Persistence on ART | PRLog
Clues to HIV Persistence on ART. Recent research has found that while antiretroviral therapy (ART) is effective at significantly reducing the number of plasma-to-T-cell transmissions of HIV, it's not as effective against T-cell-to-T-cell. - PR11634514
Refine by Content Type:
Refine by Source:
- www.prlog.org (13)
- www.abbott.com (7)
- www.hopkinsmedicine.org (4)
- www.prweb.com (4)
- www.pharmamanufacturing.com (2)
- newsroom.martek.com (1)
- www.infectioncontroltoday.com (1)
- www.medpagetoday.com (1)
